Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E- deficient mice

Circulation

Volumn 100, Issue 5, 1999, Pages 533-540

  Rouis, M ^a   Adamy, C ^c   Duverger, N ^b   Lesnik, P ^a   Horellou, P ^a   Moreau, M ^a   Emmanuel, F ^b   Caillaud, J M ^a   Laplaud, P M ^a   Dachet, C ^a   Chapman, M J ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SANOFI   (France)

^c NONE

Author keywords

Apolipoproteins; Atherosclerosis; Genes; Metalloproteinases

Indexed keywords

ALPHA ACTIN; APOLIPOPROTEIN E; COLLAGEN; COMPLEMENTARY DNA; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VIRUS VECTOR;

ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; ZYMOGRAPHY;

EID: 0033520042     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.5.533     Document Type: Article

References (43)

1. Falk E. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1983;50:127-134.
2. Davies MJ, Richardson PD, Wolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerosis plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69: 377-381.
3. Moreno MJ, Falk E, Palacios IF, Newell JB, Fuster V, Fallen JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
4. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis. 1991;87:87-90.
5. Van der Wal AC, Becker AE, Van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
6. Libby P. The molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
7. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: purification and activation of the precursor and enzymic properties. Eur J Biochem. 1990;194:721-730.
8. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 1990;29: 5783-5789.
9. Galis ZS, Kranzhöfer R, Libby P. Thrombin promotes activation of matrix metalloproteinase-2 (MMP-2) produced by cultured smooth muscle cells. Anterioscler Thromb Vasc Biol. 1997;17:483-489.
10. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaître V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997;17:439-444.
11. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA. 1990;87:5578-5582.
12. DeClerck YA, Szpirer C, Aly M, Cassiman J, Eeckhout Y, Rousseau GG. The gene for tissue inhibitor of metalloproteinase-2 is localized on human chromosome 17q25. Genomics. 1992;14:782-784.
13. Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics. 1994;19:293-297.
14. Willard HF, Durfy SJ, Mahtan MM, Dorkins H, Davized KE, Williams BRG. Regional localization of the TIMP gene on the human X chromosome. Hum Genet. 1989;81:234-238.
15. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4. J Biol Chem. 1996;271:30375-30380.
16. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 1985;318:66-69.
17. Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA. 1986;83: 2407-2411.
18. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121-125.
19. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Hemphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA. 1991;88:8154-8158.
20. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
21. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA. 1996;93:9748-9753.
22. Busiek DF, Ross FP, McDonnell S, Murphy G, Matrisian LM, Welgus HG. The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem. 1992;13: 9087-9092.
23. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993;268:23824-23829.
24. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
25. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
26. Stratford-Perricaudet L, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992;90:626-630.
27. Crouset J, Naudin L, Orsini C, Vigne E, Ferrero L, Le RA, Benoit P, Latta M, Torrent C, Branellec D, Denefle P, Mayaux J, Perricaudet M, Yeh P. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci USA. 1997;94:1414-1419.
28. Jiao S, Cole TG, Kitchens RT, Pfleger B, Schonfeld G. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gelpermeation chromatography. Metabolism. 1990;39:155-160.
29. Rubin EM, Ishida BY, Clift SM, Krauss RM. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci U S A. 1991;88:434-438.
30. Kashyap VS, Santamarina-Fojo S, Brown DR, Perrott CL, Applebaum-Bowden D, Meyn S, Talley G, Paigen B, Maeda N, Brewer HB. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest. 1995;96: 1612-1620.
31. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther. 1990; 1:241-256.
32. Watanabe M, Yakahashi Y, Ohta T, Mai M, Sasaki T, Seiki M. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase-1 gene in nude mice. Cancer. 1996;77: 1676-1680.
33. Alexander CM, Howard EW, Bissel M, Werb Z. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol. 1996;135:1669-1677.
34. Forough R, Lea H, Starcher B, Allaire E, Clowes M, Hasenstab D, Clowes AW. Metalloproteinase blockade by local overexpression of TIMP-1 increases elastin accumulation in rat carotid artery intima. Arterioscler Thromb Vasc Biol. 1998;18:803-807.
35. Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 1994;54:5467-5473.
36. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 1992;52:701-708.
37. Khokha R, Waterhouse P, Yagel S, Lala P, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 1989;243:947-950.
38. Alexander CM, Werb Z. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol. 1992;118:727-739.
39. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. J Clin Invest. 1998;101:1478-1487.
40. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther. 1998;9:867-877.
41. Lindstedt L, Saarinen J, Kalkkinen N, Welgus H, Kovanen PT. Matrix metalloproteinases reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein AI. Abstract: 70th European Atherosclerosis Society; Geneva, Switzerland, September 6-9, 1998.
42. Ylä-Herttuala S. Vascular gene transfer. Curr Opin Lipidol. 1997;8: 72-76.
43. Duverger N, Tremp G, Caillaud J, Emmanuel F, Castro E, Fruchart JC, Steinmetz A, Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-FV. Science. 1996;273:966-968.